Clinical Trial Update: Understanding How Ketamine Brings About Rapid Improvement in OCD [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study at Stanford investigating whether ketamine can produce rapid improvement in obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING